Ptc Therapeutics, Inc 10-Q for FY2025 Q3
Ptc Therapeutics, Inc. (PTCT)
10-Q
2025-11-04
For: 2025-09-30
View Original
Added on
April 07, 2026
About this 10-Q
Ptc Therapeutics, Inc filed this 10-Q on November 4, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).
Headline figures
Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $211.01M
- up 7.2% from $196.79M a year earlier
- Net income
- $15.9M
- compared with a net loss of $106.65M a year earlier
- Diluted EPS
- $0.20
- compared with -$1.39 a year earlier